AI
Saturday, June 18, 2016 7:38:59 PM
This should come with a "Your results may vary" disclaimer. 
<blink> (smile)
"There is literally no downside to an exchange listing for legitimate shareholders in a company with legitimate prospects. "
Strangely, I muttered something very similar to myself when I placed that (thankfully small) order for (Alzheimers inc) at ~$13. Damb they were uplisting after all. It's gotta be good.
I felt differently when I sold at $6 and change.
I felt like a legitimate shareholder, does that company not have legitimate prospects? (Rhetorical)
$6 hurt but looks to have been better than having waited for the eminent recovery. It's $4 now.
I still want Ctix to uplist but unless I dump my shares on the uplist surge it will still come down to successful drugs proven by well designed trials more so than where the shares can be bought or sold doesn't it?
<blink> (smile) "There is literally no downside to an exchange listing for legitimate shareholders in a company with legitimate prospects. "
Strangely, I muttered something very similar to myself when I placed that (thankfully small) order for (Alzheimers inc) at ~$13. Damb they were uplisting after all. It's gotta be good.
I felt differently when I sold at $6 and change.
I felt like a legitimate shareholder, does that company not have legitimate prospects? (Rhetorical)
$6 hurt but looks to have been better than having waited for the eminent recovery. It's $4 now.
I still want Ctix to uplist but unless I dump my shares on the uplist surge it will still come down to successful drugs proven by well designed trials more so than where the shares can be bought or sold doesn't it?
LEGEND OF ABBREVIATIONS
B = Brilacidin, the antibiotic
K = Kevetrin, the oncology drug
P = Prurisol, the psoriasis drug
SAE = Serious Adverse Event
IND = Investigational New Drug
